Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-03-06

Clinical Trial Update: Prevention of Prostate Cancer With Dutasteride in Case of High Grade PIN Neoplasia [Phase 3]

View source ↗

Summary

A Phase 3 trial assessing whether dutasteride can prevent prostate cancer in men with high-grade prostatic intraepithelial neoplasia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dutasteride (Avodart) (dutasteride)

Snippet

Sponsor: Kaunas University of Medicine | Conditions: Prostate Cancer | Phase 3 | Status: COMPLETED